Abstract-To indentify the histamine-receptors in the canine myocardium, experiments were performed in the canine heart-lung preparation supported by a donor.
were performed in the canine heart-lung preparation supported by a donor. 
MATERIALS AND METHODS
Experiments were performed in the canine heart-lung preparation supported by a donor, the details of which were described in previous publications (11, 12) . Table I are summarized the numerical data of the effects of hista mine on the cardiohemodynamic parameters.
In Fig. 3 is plotted the increase in the coronary blood flow produced by 50-300 /Ig of histamine against the increase in the myocardial oxygen consumption. Only a slight increase in the oxygen consumption was observed, indicating that the substance exerted a direct dilatatory effect on the coronary vasculature.
Effects of antihistaniinics
Pretreatment of the preparation with a representative histamine H.,-receptor antagonist, (Exp. No. 155; dog, male 9 kg; heart weight 72 g). Total blood volume at the beginning of the experiment was 1000 ml. in Fig. 4 Fig. 1 .
A prototype H1-receptor antagonist, mepyramine, in doses of 2-5 mg, resulted in a complete inhibition of the positive chronotropic effects and a definite inhibition of the increase in the coronary blood flow (Fig. 5 and Table 1 ). The positive inotropic effect of histamine remained unchanged even in the presence of this dose of mepyramine.
Mepyramine itself produced a slight negative chronotropic effect in doses above 2 nag:
Before mepyramine, the heart rate was 138.8-L7. Table 1 . Antagonistic effects of either mepyramine (3 mg or more) or metiamide (10 mg or more) last for more than two hours in this preparation.
Effects of adrenergic 8-blocking agents Pretreatment of the preparation with adrenergic beta-blocking agents, propranolol (0.1-0.3 nag) or Ko 1400 (1 mg), which was capable of abolishing the effects of 3-10 /eg of noradrenaline, was without any significant effect either on the cardio-stimulatory effects or on the coronary vasodilatatory effect of histamine.
FIG. 5.
Inhibition by mepyramine and metiamide on the effects of histamine on the heart-lung preparation supported by a donor (Exp. No. 152; dog, male, 10 kg; heart weight 84 g). Total blood volume at the beginning of the experiment was 1200 mi. Abbreviations are the same as in Fig. 1 .
DISCUSSIONS
The present study clearly demonstrated that a combined used of both the H1 and H2-receptor antagonists is needed to suppress the positive inotropic effect of histamine in the canine myocardium. Either H1 or H2-antagonists was without effects, if administered separately.
As far as we know, this is the first demonstration of the histamine receptors that cannot be classified either as H1 or H2. In contrast, the positive chronotropic effect was abolished with Hl-receptor antagonist, and such is in agreement with the recent findings of Chiba (10) . Thus, unlike the histamine-receptor in the guinea pig atrium, the histamine receptor in the dog atrial myocardium subserving the positive chronotropic effect is to be classified as H1-type receptor.
Flacke et al. (13) demonstrated in the dog heart-lung preparation that the increase in the heart rate produced by larger doses of histamine was blocked by propranolol, and suggested that the substance had a catecholamine-releasing action.
The catecholamine releasing action of histamine was also demonstrated in the isolated atrial preparation of the guinea pig concerning the mechanism of action of hydralazine and the receptor re sponsible for this action of histamine was classified as H1 (14) . However, in the present study the positive chronotropic effects of this compound, although inhibited with H,-receptor blocking agent, were not affected with adrenergic beta-blocking agents, invalidating the hypothesis that the positive chronotropic effect of histamine is related to a release of catecholamine.
In the present study, only an increase in the coronary blood flow was observed with smaller doses of histamine in the complete absence of the cardio-stimulatory effects, indicating that a predominant effect of this substance in the canine myocardium is not a cardio stimulation, but a direct dilatation of the coronary vasculature. The discrepancy between the results of Broadley (16) and our own can be ascribed to the species difference as described with respect to the cardio stimulatory actions of this compound in the "introduction" section.
